BioHealth News Archive
Supervisory Technology Licensing Specialist at Department Of Health And Human Services
The NIH is the premier biomedical research center for the world. Its 27 Institutes and Centers employ approximately 18,000 employees doing a vast array…
Read MoreMedImmune to close Santa Clara and Mountain View sites, but will keep Hayward open as it cuts 200 jobs – San Jose Mercury News
MedImmune will chop 200 jobs and close its Mountain View and Santa Clara locations, but will beef up its Hayward site, the provider of…
Read MoreGlaxoSmithKline to buy Human Genome Sciences for $14.25 per share – Washington Business Journal
Rockville-based Human Genome Sciences Inc., which rejected a $13-per-share takeover offer from GlaxoSmithKline PLC as too low, has accepted a $14.25 per share offer…
Read MoreGlaxoSmithKline wins takeover bid for Human Genome
U.K. drug maker GlaxoSmithKline said Monday it had secured its takeover of Rockville-based Human Genome Sciences after agreeing to pay a higher price for…
Read MoreGlaxo Is Said to Be Near a Deal for Human Genome Sciences – NYTimes.com
GlaxoSmithKline of Britain is near a deal to buy the biopharmaceutical company Human Genome Sciences on friendly terms for about $2.8 billion, potentially ending…
Read MoreWesley Blakeslee from Johns Hopkins University Tech. Transfer, “The Business Concierge to Johns Hopkins University” Video Interview at BioMaryland Booth at BIO International 2012 | Stock News Now
The Johns Hopkins Technology Transfer Office (JHTT) is the University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent,…
Read MoreNew Johns Hopkins center to focus on broad use of health IT tools – FierceHealthIT
Johns Hopkins University is creating a new center to help public health agencies and accountable provider or payer groups better take advantage of health…
Read MoreJohns Hopkins Community helps scientists – Wes Blakeslee – Johns Hopkins Technology Transfer – YouTube
What kind of community does Johns Hopkins offer for a scientist? An excerpt of an interview in November of 2011, with Wes Blakeslee, Executive…
Read MoreHuman Genome Science looks to expand biotech sales jobs with new anthrax treatment
As more drug manufacturers fight for a share of the market, those with biotech sales jobs understand that their companies' success lies in its…
Read MoreVenture Debt: Under-Appreciated Tool for Building Biotechs – Forbes
Cash-burning R&D-stage biotechs have big appetites for cash, which is typically addressed with an equity-based diet. It’s also supported through corporate partnerships and other…
Read MoreMaryland Venture Fund names Thomas Dann as head – Washington Business Journal
Maryland has named a longtime venture capitalist to head its program for investing in startups and early-stage companies. Thomas Dann, founder and managing director…
Read MoreEast Coast accelerator DreamIt Ventures moving into healthcare IT
Healthcare IT has become a new priority for East Coast accelerator DreamIt Ventures with the hire of a veteran angel investor group director. Karen…
Read MoreObama Signs FDA Bill | The Scientist
President Barack Obama signed the US Food and Drug Administration Safety and Innovation Act (S. 3187) into law, reauthorizing user fees that the FDA…
Read MoreHuman Genome Sciences Announces Resubmission of Raxibacumab BLA to FDA
Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License…
Read MoreMedStartr Offers Crowdfunding for Health IT Firms, Including Itself | Xconomy
A couple years ago, when Alex Fair was tossing around ideas on how to raise money for his new healthcare marketplace, FairCareMD, he knew…
Read More